Artia Global Partners’s AbbVie ABBV Stock Holding History

Artia Global Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.15M	Hold	14,500	–	–	0.63%	31
2025 Q4	$3.31M	Hold	14,500	–	–	0.47%	31
2025 Q3	$3.36M	Hold	14,500	–	–	0.53%	27
2025 Q2	$2.69M	Buy	+14,500	New	+$2.69M	0.65%	21
2024 Q2	–	Sell	-90,821	Closed	-$16.5M	–	47
2024 Q1	$16.5M	Hold	90,821	–	–	3.32%	6
2023 Q4	$14.1M	Hold	90,821	–	–	4.09%	7
2023 Q3	$13.5M	Hold	90,821	–	–	5.63%	5
2023 Q2	$12.2M	Hold	90,821	–	–	4.22%	6
2023 Q1	$14.5M	Hold	90,821	–	–	5.35%	5
2022 Q4	$14.7M	Buy	+90,821	New	+$13.9M	5.59%	6

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artia Global Partners's ABBV Position: Q1 2026 in Review

Artia Global Partners held its AbbVie (ABBV) position steady in Q1 2026 at 14,500 shares worth $3.15M. The position accounts for 0.63% of the portfolio, ranked #31.

Artia Global Partners first reported a position in ABBV in Q4 2022 and has held it in 10 quarters since. The position peaked at $16.5M in Q1 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Artia Global Partners held 14,500 shares of AbbVie worth $3.15M as of Q1 2026.
Artia Global Partners left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.63% of Artia Global Partners's portfolio in Q1 2026, its #31 holding.
Artia Global Partners first reported a position in AbbVie in Q4 2022 and has held it in 10 quarters since.
Artia Global Partners's AbbVie position peaked at $16.5M in Q1 2024.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.